Breast and Cervical Cancer

Share

Mammograms save lives. But, even today, too many women don't have access to lifesaving breast and cervical cancer screenings.

We are working in Congress and in every state legislature to ensure funding for the federal cancer screening and early detection program that has already helped millions of women and saved thousands of lives.

More than 40,000 women will die from breast cancer this year, while over 13,000 will be diagnosed with cervical cancer.  We're working to convince Congress to increase funding for breast and cervical cancer research that could lead to new medical breakthroughs and save more lives.

Take Action

black woman getting scanned for breast cancer

Urge Congress to support breast & cervical cancer screenings

Since 1991, the National Breast & Cervical Cancer Early Detection Program has provided more than 15 million breast and cervical cancer screenings to those who need them most. Before the end of the year, Congress must pass legislation that supports this program. Cancer can't wait.

Latest Updates

November 15, 2024
Massachusetts

Legislation will eliminate costly barriers to follow up breast cancer screening

November 4, 2024
Massachusetts

S.2971, An Act relative to medically necessary breast screenings and exams for equity and early detection requires that health plans regulated by the Commonwealth cover medically necessary screening and diagnostic breast imaging with no out- of-pocket costs.

October 2, 2024
Hawaii

The American Cancer Society (ACS) released an update this week on breast cancer occurrence and trends in the United States. While the new report finds mortality rates have dropped by 44% since 1989, not all women have benefited from this progress. The report highlighted a continued upward trend in breast cancer incidence with the steepest increase in women younger than 50 years and Asian American/Pacific Islander (AAPI) women of all ages. The release coincides with the American Cancer Society Cancer Action Network’s (ACS CAN) campaign to connect patients with the right treatment at the right time through increasing access to biomarker testing in Hawaii.

September 19, 2024
Missouri

Washington, D.C., – Emily Kalmer was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocating for cancer-fighting public policies. ACS CAN, the advocacy affiliate of the American Cancer Society, presents the award to

Breast and Cervical Cancer Resources

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

Approximately 1 in 8 women (13%) will be diagnosed with invasive breast cancer in her lifetime, and 1 in 39 women (3%) will die from breast cancer. In 2023, an estimated 297,790 women in the U.S. will be diagnosed with invasive breast cancer, and 43,170 will die from the disease. Despite the fact that U.S. breast cancer death rates have been declining for several decades, not all people have benefited equally from the advances in prevention, early detection, and treatments that have helped achieve these lower rates.

Our ability to continue to make progress against cancer relies heavily on eliminating inequities that exist in breast cancer prevention and treatment. That is why ACS CAN advocates for policies to reduce the disparities in breast cancer by improving access to prevention and early detection services, patient navigation services, insurance coverage, in-network facilities, and clinical trials.

  •